Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2025-01-08 00:00:00 ET · period of report 2024-10-31 · accession 0001628280-25-000984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-08 | 2024-10-31 | BLFS | DE GREEF RODERICK | Pres, CEO, Dir | S - Sale | $23.43 | -46.9K | 415.0K | -10% | -$1.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-31 | S | D | 46,896 | $23.43 | 414,958 | D | — | — |